Showing results (211-220 of 255) with videos related to
Sort By:
Pageof 26
Journal of Crohn'S & Colitis|October 1, 2015
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine AnaloguesK J Schmidt, N Müller, A Dignass, et al.Alimentary Pharmacology & Therapeutics|March 24, 2009
Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's diseaseK J Schmidt, K Fellermann, P Wellhöner, et al.Science (New York, N.Y.)|August 27, 1971
Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsiesL Horta-Barbosa, R Hamilton, B Wittig, et al.Alimentary Pharmacology & Therapeutics|June 25, 2009
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's diseaseI Kübler, M J Koslowski, M Gersemann, et al.Leukemia & Lymphoma|March 1, 1997
Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemiasA Neubauer, A Burchert, C Maiwald, et al.Digestive Diseases and Sciences|June 18, 2002
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensinsJ Wehkamp, B Schwind, K R Herrlinger, et al.The EMBO Journal|October 2, 1995
Subunit composition of G(o) proteins functionally coupling galanin receptors to voltage-gated calcium channelsF Kalkbrenner, V E Degtiar, M Schenker, et al.Tissue Antigens|July 8, 2000
Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5)M Scholz, R A Blaheta, B Wittig, et al.Alimentary Pharmacology & Therapeutics|March 8, 2003
6-thioguanine--efficacy and safety in chronic active Crohn's diseaseK R Herrlinger, W Kreisel, M Schwab, et al.Alimentary Pharmacology & Therapeutics|June 12, 2004
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's diseaseK R Herrlinger, K Fellermann, C Fischer, et al.Pageof 26